Clinical Trials Browser

Phase 1/2 × Carcinoma, Ovarian Epithelial × aldesleukin × Clear all

NCT00019916 2013-06-20

Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer

Phase 1/2 Completed

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Ovarian Neoplasms